首页> 外文期刊>Journal of Labelled Compounds and Radiopharmaceuticals >Synthesis of C-11-labeled ubiquinone and ubiquinol via Pd-0-mediated rapid C-[C-11]methylation using [C-11]methyl iodide and 39-demethyl-39-(pinacolboryl)ubiquinone
【24h】

Synthesis of C-11-labeled ubiquinone and ubiquinol via Pd-0-mediated rapid C-[C-11]methylation using [C-11]methyl iodide and 39-demethyl-39-(pinacolboryl)ubiquinone

机译:使用[C-11]甲基碘和39-脱乙基-39-(Pinacolboryl)ubiquinone通过PD-0介导的快速C-C-11]甲基化合成C-11标记的泛喹和泛醇。

获取原文
获取原文并翻译 | 示例
       

摘要

To enable positron emission tomography (PET) imaging of the in vivo kinetics of ubiquinone and ubiquinol, which is referred to as coenzyme Q(10), their C-11-radiolabeled counterparts were synthesized herein. C-11-Labeled ubiquinone [C-11]-1 was realized by Pd-mediated rapid C-[C-11]methylation of [C-11]CH3I with 39-demethyl-39-(pinacolboryl)ubiquinone, prepared by Ru-catalyzed olefin metathesis of unradiolabeled ubiquinone with 2-(pinacolboryl)propene. Subsequent reduction of [C-11]-1 using Na2S2O4 yielded C-11-labeled ubiquinol [C-11]-2. The synthesis time and [C-11]CH3I-based radiochemical yield of [C-11]-1 were within 36 minutes and up to 53%, while those of [C-11]-2 were within 38 minutes and up to 39%, respectively. After radiopharmaceutical formulation, the qualities of [C-11]-1 and [C-11]-2 were confirmed to be applicable for animal PET studies. The analytical values of [C-11]-1 and [C-11]-2 are as follows: radioactivity of up to 3.5 and 1.4 GBq, molar activity of 21 to 78 and 48 to 76 GBq/mu mol, radiochemical purity of greater than 99% and greater than 95%, and chemical purity of greater than 99% and 77%, respectively. The concept behind this radiolabeling procedure is that unradiolabeled natural ubiquinone can be converted to C-11-radiolabeled ubiquinone and ubiquinol via a pinacolborane-substituted ubiquinone derivative. Each PET probe was used for molecular imaging using rats to investigate the in vivo kinetics and biodistribution of the coenzyme Q(10).
机译:为了使正电子发射断层扫描(PET)成像在泛醌和泛醇的体内动力学中,其被称为辅酶Q(10),本文合成了其C-11-放射性标记的对应物。通过PD介导的C-11标记的泛醌[C-11] -1,用Ru制备的[C-11] CH3I的[C-11] CH 3 I的快速C-C-[C-11]甲基化。用Ru制备的泛醌 - 用2-(PINACOLBORYL)丙烯催化烯烃的烯烃复分解。随后使用Na 2 O 4减去[C-11] -1,得到C-11标记的ubiquinol [C-11] -2。 [C-11] -1的合成时间和[C-11]基于CH3I的放射化学产率在36分钟内,高达53%,而[C-11] -2的含量在38分钟内,高达39 %, 分别。放射性药物制剂后,证实[C-11] -1和[C-11] -2的质量适用于动物宠物研究。 [C-11] -1和[C-11] -2的分析值如下:放射性高达3.5和1.4 GBQ,摩尔活性为21至78和48至76GBq / mumol,放射化学纯度分别大于99%且大于95%,化学纯度分别大于99%和77%。这种放射性标记程序背后的概念是通过PINACOLBOOLANE-取代的泛醌衍生物转化为C-11-放射性标记的泛醌和泛醇的概念。每个PET探针用于使用大鼠进行分子成像,研究辅酶Q(10)的体内动力学和生物分布。

著录项

  • 来源
  • 作者单位

    RIKEN Ctr Biosyst Dynam Res Lab Labeling Chem Kobe Hyogo Japan;

    Kaneka Corp Pharma &

    Supplemental Nutr Solut Vehicle Takasago Hyogo Japan;

    Kaneka Corp Pharma &

    Supplemental Nutr Solut Vehicle Takasago Hyogo Japan;

    RIKEN Ctr Biosyst Dynam Res Lab Pathophysiol &

    Hlth Sci Kobe Hyogo Japan;

    Kaneka Corp Pharma &

    Supplemental Nutr Solut Vehicle Tokyo Japan;

    RIKEN Ctr Biosyst Dynam Res Lab Pathophysiol &

    Hlth Sci Kobe Hyogo Japan;

    RIKEN Ctr Biosyst Dynam Res Lab Labeling Chem Kobe Hyogo Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

  • 入库时间 2022-08-20 09:30:08

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号